AI in pharmacovigilance automates adverse event monitoring, signal classification, and periodic report generation (PSUR). Reduces reporting time by 50-70% and ensures EMA/AIFA compliance. Critical for pharmaceutical SMEs with limited resources.
This is an abridged translation. For the full content, please refer to the Italian version.
Contact us for a free consultation. Also read our article on AI in pharmaceuticals and medical devices.